Median survival (months) | 2 year survival | 3 year survival | 4 year survival | 5 year survival | |
---|---|---|---|---|---|
Radiation | 11.8 | 5.7 % | 2.3 % | 2.3 % | 0% |
Radiation and temozolomide | 10.9 | 21.8 % | 12.3 % | 8.8 % | 6.5 % |
From: Stupp et al. Lancet Oncol 2009. Patients over the age of 60